COMP <GO>
AROC vs CVX // REVENUE GROWTH (YOY)
Archrock Inc. (NYSE) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: AROC 10
— CVX 5
▲ REVENUE GROWTH (YOY) LEADER: AROC
LAST: $31.70 (-1.25%) • MKT CAP: $5.63B
revenue-growth
28.70%
LAST: $235.52 (+1.75%) • MKT CAP: $457.31B
revenue-growth
-4.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AROC VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AROC | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.60% | 41.30% | +7.30 | AROC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.00% | 5.80% | +2.20 | AROC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.9x | 21.5x | -3.60 | AROC | /valuation <GO> |
| Free Cash Flow Yield | 9.86% | 5.61% | +4.25 | AROC | /fcf-yield <GO> |
| Operating Margin | 26.40% | 8.10% | +18.30 | AROC | /operating-margins <GO> |
| Net Profit Margin | 21.60% | 6.70% | +14.90 | AROC | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 28.70% | -4.60% | +33.30 | AROC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.52% | 2.79% | -0.27 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.13 | 3.71 | -2.58 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | AROC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 7.10% | -0.60 | AROC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.8 | 72.8 | -15.05 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 1.07 | -0.18 | CVX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 14.7x | 34.6x | -19.90 | AROC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.63B | $457.31B | -$451.68B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AROC REV | CVX REV | AROC GROSS % | CVX GROSS % | AROC FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.49B | $184.43B | 48.6% | 41.3% | $555.1M | $25.64B |
| FY 2024 | $1.16B | $193.41B | 43.7% | 38.4% | $377.5M | $22.79B |
| FY 2023 | $990.3M | $196.91B | 44.0% | 44.0% | $265.6M | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AROC // BETA 0.89
CVX // BETA 1.07